HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
WEDNESDAY, Sept. 30, 2015 (HealthDay News) -- An abbreviated magnetic resonance imaging (MRI) protocol can exclude malignancy in women with suspicious X-ray mammography screening, according to a study published online Sept. 29 in Radiology.
Sebastian Bickelhaupt, M.D., from the German Cancer Research Center in Heidelberg, and colleagues conducted a prospective study involving 50 women with suspicious screening X-ray mammograms. The authors sought to examine the ability of a diagnostic abbreviated MRI protocol consisting of maximum intensity projections (MIPs) from diffusion-weighted imaging with background suppression (DWIBS) and unenhanced morphologic sequences to help predict the likelihood of malignancy. Participants underwent two abbreviated protocols based on MIPs and the findings were compared with those of the full diagnostic protocol and histopathologic findings. Twenty-four participants had a breast carcinoma.
The researchers found that the sensitivity was 0.92, specificity 0.94, negative predictive value (NPV) 0.92, and positive predictive value (PPV) 0.93 for DWIBS. The mean reading time was 29.7 seconds; in the absence of suspicious findings on the DWIBS MIPs, the mean reading time was less than three seconds. With the second abbreviated protocol (subtraction images from the first post-contrast and the unenhanced series), the sensitivity, specificity, NPV, and PPV were 0.85, 0.90, 0.87, and 0.89, respectively; the mean reading time was 29.6 seconds.
"Unenhanced diagnostic MR imaging (DWIBS mammography), with an NPV of 0.92 and an acquisition time of less than seven minutes, could help exclude malignancy in women with suspicious X-ray screening mammograms," the authors write.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on May 31, 2022